Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Phuong, LK, Curtis, N, Gowdie, P, Akikusa, J, Burgner, D.
Treatment Options for Resistant Kawasaki Disease..
Paediatr Drugs
20(1)
:
59 -80
2018
view publication
Burgner, DP, Miller, JE, Strunk, T, Nassar, N.
Growth Parameters, Effect Measure Modification and the Association Between Vaccination and Early Childhood Hospitalization With Non-targeted Infections..
Clin Infect Dis
66(2)
:
318 -319
2018
view publication
Chen, KYH, Messina, N, Germano, S, Bonnici, R, Freyne, B, Cheung, M, Goldsmith, G, Kollmann, TR, Levin, M, Burgner, D, et al.
Innate immune responses following Kawasaki disease and toxic shock syndrome..
PLoS One
13(2)
:
e0191830
2018
view publication
Chen, KYH, Curtis, N, Cheung, M, Burgner, D.
Cardiovascular Risk After Kawasaki Disease - Findings From an Australian Case-Control Study..
Heart Lung Circ
27(1)
:
6 -8
2018
view publication
Buscot, M-J, Thomson, RJ, Juonala, M, Sabin, MA, Burgner, DP, Lehtimäki, T, Hutri-Kähönen, N, Viikari, JSA, Jokinen, E, Tossavainen, P, et al.
BMI Trajectories Associated With Resolution of Elevated Youth BMI and Incident Adult Obesity..
Pediatrics
141(1)
:
2018
view publication